Clinical reasoning: Rhabdomyolysis after combined treatment with simvastatin and fluconazole

Neurology

Volumn 71, Issue 15, 2008, Pages

  Findling, O ^a   Meier, N ^a   Sellner, J ^b   Nedeltchev, K ^a   Arnold, M ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; METHYLPREDNISOLONE; SIMVASTATIN; ANTIFUNGAL AGENT; HYPOCHOLESTEROLEMIC AGENT;

AGED; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; MUSCLE BIOPSY; MUSCLE STRENGTH; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REFLEX; RHABDOMYOLYSIS; TREATMENT DURATION; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; HYPERCHOLESTEROLEMIA;

AGED; ANTICHOLESTEREMIC AGENTS; ANTIFUNGAL AGENTS; CANDIDIASIS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; HUMANS; HYPERCHOLESTEROLEMIA; RHABDOMYOLYSIS; SIMVASTATIN;

EID: 55249098833     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000327566.57661.09     Document Type: Article

References (8)

1. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine 2005; 84:377-385.
2. Moratalla MB, Braun P, Fornas GM. Importance of MRI in the diagnosis and treatment of rhabdomyolysis. Eur J Radiol 2008;65:311-315.
3. Mukhtar RY, Reckless JP. Statin-induced myositis: a commonly encountered or rare side effect? Curr Opin Lipidol 2005;16:640-647.
4. Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol 2006;97:S52-60.
5. Spina E, Scordo MG, D'Arrigo C. Metabolic drug interactions with new psychotropic agents. Fund Clin Pharmacol 2003;17:517-538.
6. Hodel C. Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol Lett 2002;128:159-168.
7. Owczarek J, Jasinska M, Orszulak-Michalak D. Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep 2005;57:23-34.
8. Jain K. Drug-Induced Neurological Disorders. 2nd ed. Göttingen- Seattle-Bern: Hogrefe & Huber; 2001:243-273.